ADMA Biologics
ADMA
$6.81
Share price
1.04%
Change (1 day)
99.12%
Change (1 year)
Categories
ADMA Biologics (ADMA) Fails to deliver data
Key failure to deliver metrics for ADMA Biologics :
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: $0 M
- Last 3 months FTD volume: $0.04 M
- Last year FTD volume: $2.11 M
Failures to deliver for ADMA Biologics (ADMA) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for ADMA Biologics (ADMA) - since 2013
Volume in USD (price x number of shares), data since 2013ADMA Biologics (ADMA) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.08 M | -97.07% |
| 2023 | $2.77 M | -66.67% |
| 2022 | $8.32 M | -64.36% |
| 2021 | $23.34 M | 54.12% |
| 2020 | $15.15 M | 146.37% |
| 2019 | $6.14 M | 408.15% |
| 2018 | $1.21 M | 44.84% |
| 2017 | $0.83 M | 115.35% |
| 2016 | $0.38 M | -15.66% |
| 2015 | $0.46 M | -60.57% |
| 2014 | $1.16 M | 134.3% |
| 2013 | $0.49 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Repligen
RGEN | $8.48 M | $0.10 B | 🇺🇸 USA |
 Novavax NVAX | $37.88 M | $0.32 B | 🇺🇸 USA |
 Cel-Sci
CVM | $0.52 M | $5.01 M | 🇺🇸 USA |